# Lactobacillus delbrueckii subsp. bulgaricus LB-51

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/lactobacillus-delbrueckii-subsp-bulgaricus-lb-51
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-31
**Evidence Score:** 2 / 10
**Category:** Fermented/Probiotic
**Also Known As:** LB-51, L. delbrueckii subsp. bulgaricus LB-51, Lactobacillus bulgaricus LB-51, Bulgarian bacillus LB-51, L. bulgaricus LB-51 strain

## Overview

Lactobacillus delbrueckii subsp. bulgaricus LB-51 is a lactic acid-producing bacterial strain that ferments lactose and other sugars to produce L-(+)-lactic acid. While primarily used in industrial fermentation processes, its potential [probiotic](/ingredients/condition/gut-health) properties have not been clinically validated.

## Health Benefits

• No clinical health benefits documented - No human trials available for LB-51
• Fermentation capability only - Produces up to 75 g/L L-(+)-lactic acid in industrial settings
• Potential [probiotic](/ingredients/condition/gut-health) properties unstudied - No evidence for gut health effects
• Yogurt production role - Traditional use in dairy fermentation only
• Safety profile unknown - No clinical safety data available

## Mechanism of Action

LB-51 metabolizes lactose and glucose through the homofermentative pathway, utilizing the enzyme lactate dehydrogenase to convert pyruvate into L-(+)-lactic acid. The strain produces up to 75 g/L lactic acid concentration in controlled fermentation environments. Its theoretical [probiotic](/ingredients/condition/gut-health) mechanisms would involve adhesion to intestinal epithelial cells and competitive exclusion of pathogenic bacteria, though these pathways remain unverified for this specific strain.

## Clinical Summary

No human clinical trials have been conducted on Lactobacillus delbrueckii subsp. bulgaricus LB-51 to evaluate its health effects. The strain has only been studied in industrial fermentation research focusing on lactic acid production efficiency. Unlike other Lactobacillus strains with established probiotic benefits, LB-51 lacks peer-reviewed evidence for [digestive health](/ingredients/condition/gut-health), [immune function](/ingredients/condition/immune-support), or other therapeutic applications. Current data is limited to in vitro fermentation studies demonstrating its acid production capabilities.

## Nutritional Profile

Lactobacillus delbrueckii subsp. bulgaricus LB-51 is a bacterial culture strain, not a direct source of macronutrients or micronutrients in conventional terms. As a lactic acid bacterium, its primary metabolic output is L-(+)-lactic acid (up to 75 g/L in industrial fermentation), which contributes to the acidic environment of fermented dairy products. During yogurt fermentation, LB-51 activity contributes indirectly to nutrient availability: lactose is partially hydrolyzed to glucose and galactose via bacterial beta-galactosidase activity, improving digestibility for lactose-sensitive individuals. The strain produces trace B-vitamins as metabolic byproducts — primarily folate (B9) and riboflavin (B2) — at low concentrations consistent with other L. delbrueckii strains (typically <0.1 mg per 100g fermented product). Bacterial cell walls contain peptidoglycan and lipoteichoic acids, which are bioactive compounds with potential [immunomodulatory](/ingredients/condition/immune-support) signaling capacity, though concentrations in consumed doses are minimal. Exopolysaccharides may be produced, contributing texture rather than significant caloric value. Bioavailability of any direct nutritional contribution is negligible given typical [probiotic](/ingredients/condition/gut-health) dosing; its value lies in substrate transformation rather than direct nutrient delivery.

## Dosage & Preparation

No clinically studied dosage ranges are reported for LB-51 in any supplemental form. The strain has only been documented in fermentation media producing lactic acid, with no established [probiotic](/ingredients/condition/gut-health) dosing or CFU standardization. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Safety data for LB-51 is not available from clinical studies, though related Lactobacillus delbrueckii strains are generally recognized as safe (GRAS) for food use. Theoretical side effects could include mild digestive upset, gas, or bloating if consumed as a [probiotic](/ingredients/condition/gut-health) supplement. No drug interactions have been documented for this specific strain. Pregnant and breastfeeding women should avoid LB-51 supplements due to lack of safety testing in these populations.

## Scientific Research

No human clinical trials, RCTs, or meta-analyses were found specifically for Lactobacillus delbrueckii subsp. bulgaricus LB-51. While the general L. delbrueckii subsp. bulgaricus species has been studied in yogurt fermentation contexts, no PubMed citations or clinical endpoints are available for the LB-51 strain as a [probiotic](/ingredients/condition/gut-health) supplement.

## Historical & Cultural Context

L. delbrueckii subsp. bulgaricus has historical use in Bulgarian yogurt fermentation within traditional dairy practices, though no specific timeline is documented for the LB-51 strain. Plant-isolated related strains suggest potential natural environmental roles, but formalized traditional medicine applications are not established.

## Synergistic Combinations

LB-51 pairs functionally with Streptococcus thermophilus, its classic yogurt co-culture partner, through protocooperation: S. thermophilus produces formate and CO2 that stimulate LB-51 growth, while LB-51 releases amino acids (particularly valine, leucine, and histidine via proteolysis of casein) that feed S. thermophilus, collectively enhancing lactic acid production and flavor compound development. Pairing with Lactobacillus acidophilus LA-5 or NCFM creates a complementary probiotic matrix — while LB-51 lacks documented intestinal colonization capacity, L. acidophilus contributes documented mucus-adherence and bile tolerance, effectively covering the gut health pathway that LB-51 does not address. Additionally, combining LB-51 fermented medium with [prebiotic](/ingredients/condition/gut-health) inulin or fructooligosaccharides (FOS at 3–5g doses) may support the survival and activity of co-administered bifidobacteria, as LB-51's acidification creates a selectively favorable pH environment (~4.0–4.5) that inhibits pathogens while the FOS selectively feeds beneficial anaerobes, creating an additive protective effect in the final fermented product.

## Frequently Asked Questions

### What does Lactobacillus delbrueckii subsp. bulgaricus LB-51 do in the body?

The specific effects of LB-51 in the human body have not been clinically studied. While it produces lactic acid through fermentation, there is no evidence that it provides probiotic benefits like improved digestion or immune support when consumed as a supplement.

### Is LB-51 the same as regular Bulgarian yogurt cultures?

LB-51 is a specific industrial strain of Lactobacillus delbrueckii subsp. bulgaricus, while traditional yogurt uses different strains of the same subspecies. LB-51 is optimized for high lactic acid production rather than yogurt-making or probiotic properties.

### How much lactic acid does LB-51 produce?

Laboratory studies show that LB-51 can produce up to 75 grams per liter of L-(+)-lactic acid under optimal fermentation conditions. This high production capacity makes it valuable for industrial applications but doesn't translate to health benefits.

### Can LB-51 survive stomach acid like other probiotics?

The acid tolerance and survival rates of LB-51 in human gastric conditions have not been tested. Without clinical data on its viability through digestion, its potential to reach the intestines and function as a probiotic remains unknown.

### Are there any proven health benefits of LB-51 supplements?

No health benefits of LB-51 have been proven through clinical trials. Unlike well-studied probiotic strains, LB-51 has only been researched for industrial fermentation purposes and lacks evidence for digestive health, immune support, or other therapeutic effects.

### Is LB-51 safe for children or the elderly?

Clinical safety data for Lactobacillus delbrueckii subsp. bulgaricus LB-51 in children or elderly populations is not available. While the strain is traditionally used in yogurt production with a long history of culinary use, no formal safety studies have been conducted on supplemental forms of LB-51 in these age groups. Medical consultation is recommended before use in vulnerable populations.

### Does LB-51 interact with common medications or antibiotics?

No drug interaction studies have been conducted for Lactobacillus delbrueckii subsp. bulgaricus LB-51. However, antibiotics may reduce probiotic viability if taken concurrently, and immunosuppressive medications may affect probiotic colonization potential—though these interactions have not been specifically evaluated for this strain. Consult a healthcare provider before combining LB-51 supplements with medications.

### What is the difference between LB-51 as a supplement versus LB-51 in yogurt?

Supplemental forms of LB-51 typically contain higher, standardized bacterial counts compared to naturally fermented yogurt, though the actual viable cell count varies by product. Yogurt provides LB-51 alongside food matrix components and additional fermentation byproducts, while supplements isolate the strain itself. No comparative efficacy studies exist to determine whether one delivery form is superior to the other.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*